Autism Spectrum Disorder Clinical Trials in New York, New York

7 studies are recruiting for autism spectrum disorder in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Phase 2A Trial of DT402 for Autism Spectrum Disorder

   A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   Spectrum Neuroscience and Treatment Institute, New York, New York

   Run by

   Definium Therapeutics US, Inc.

   See if you can join NCT07303907 on ClinicalTrials.gov

2. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

   This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism spectrum disorder.

   Stage

   Phase 3

   Ages

   5 to 17

   Site

   NYU Child Study Center, New York, New York

   Locations

   64 in total

   Run by

   Intra-Cellular Therapies, Inc.

   See if you can join NCT06229210 on ClinicalTrials.gov

3. FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

   FOXP1, also known as Forkhead-box Protein P1, is a transcription factor protein belonging to the FOX gene family. Disruptions in the FOXP1 gene cause a phenotype characterized by global developmental delay, speech deficits, mild dysmorphic features, and traits of autism spectrum disorder. This stud…

   Stage

   Not phased

   Ages

   2 and older

   Site

   The Seaver Autism Center for Research and Treatment, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT03718923 on ClinicalTrials.gov

4. Longitudinal Study of Neurogenetic Disorders

   The purpose of this study is to analyze patterns in individuals with hnRNP (and other) genetic variants, including their neurological comorbidities, other medical problems and any treatment. The investigators will maintain an ongoing database of medical data that is otherwise being collected for ro…

   Stage

   Not phased

   Ages

   Any age

   Site

   Columbia University Irving Medical Center, New York, New York

   Run by

   Columbia University

   See if you can join NCT03492060 on ClinicalTrials.gov

5. Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

   This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.

   Stage

   Phase 2

   Ages

   5 to 18

   Site

   New York University (NYU) Langone, New York, New York

   Locations

   2 in total

   Run by

   Montefiore Medical Center

   See if you can join NCT03202303 on ClinicalTrials.gov

6. Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

   This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.

   Stage

   Not phased

   Ages

   2 to 8

   Site

   Mt. Sinai Medical Center, New York, New York

   Locations

   2 in total

   Run by

   State University of New York - Upstate Medical University

   See if you can join NCT06006637 on ClinicalTrials.gov

7. ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

   ADNP, also known as Activity Dependent Neuroprotective Protein, is a rare neurodevelopmental disorder caused by mutations encompassing the ADNP gene on chromosome 20. Clinically, ADNP syndrome is characterized by intellectual disability and global developmental delay. This study seeks to characteri…

   Stage

   Not phased

   Ages

   2 and older

   Site

   The Seaver Autism Center for Research and Treatment, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT03718936 on ClinicalTrials.gov